DC Circ. Boosts Teva In Row With FDA Over Merck Drugs
Teva Pharmaceutical Industries Ltd. has been given a renewed shot at the market for hypertension drugs, with a federal appeals court granting the Israeli drugmaker 180 days to exclusively sell its...To view the full article, register now.
Already a subscriber? Click here to view full article